Regulation of signal transduction.

[1]  R. L. Singhal,et al.  Linkage of reduction in 1-phosphatidylinositol 4-kinase activity and inositol 1,4,5-trisphosphate concentration in human ovarian carcinoma cells treated with quercetin. , 1995, Life sciences.

[2]  R. L. Singhal,et al.  1-Phosphatidylinositol 4-phosphate 5-kinase (EC 2.7.1.68): a proliferation- and malignancy-linked signal transduction enzyme. , 1994, Cancer research.

[3]  M. Rizzo,et al.  1-Phosphatidylinositol 4-kinase: an enzyme linked with proliferation and malignancy. , 1994, Cancer research.

[4]  R. L. Singhal,et al.  Antimetabolites reduce the activities of enzymes with short half-lives in addition to inhibiting their specific targets. , 1994, Advances in experimental medicine and biology.

[5]  G. Sledge,et al.  Coordinated increase in activities of the signal transduction enzymes PI kinase and PIP kinase in human cancer cells. , 1994, Life Science.

[6]  G. Weber,et al.  Targeted and non-targeted actions of anti-cancer drugs. , 1994, Advances in enzyme regulation.

[7]  R. L. Singhal,et al.  Sequential impact of tiazofurin and ribavirin on the enzymic program of the bone marrow. , 1993, Cancer research.

[8]  P. Hughes,et al.  Novel inositol containing phospholipids and phosphates: their synthesis and possible new roles in cellular signalling , 1993, Current Opinion in Neurobiology.

[9]  A. Shamsuddin,et al.  [3H]phytic acid (inositol hexaphosphate) is absorbed and distributed to various tissues in rats. , 1993, The Journal of nutrition.

[10]  M. Berridge.  Inositol trisphosphate and calcium signalling , 1993, Nature.

[11]  J. Eble,et al.  Inhibition by tiazofurin of inosine 5'-phosphate dehydrogenase (IMP DH) activity in extracts of ovarian carcinomas. , 1992, Gynecologic oncology.

[12]  H. Nakamura,et al.  Methotrexate decreases thymidine kinase activity. , 1992, Biochemical and biophysical research communications.

[13]  R. Anderson,et al.  The human erythrocyte contains two forms of phosphatidylinositol-4-phosphate 5-kinase which are differentially active toward membranes. , 1990, The Journal of biological chemistry.

[14]  S. Ichikawa,et al.  Azidothymidine inhibition of thymidine kinase and synergistic cytotoxicity with methotrexate and 5-fluorouracil in rat hepatoma and human colon cancer cells. , 1990, Cancer communications.

[15]  K. Umezawa,et al.  Screening of phosphatidylinositol kinase inhibitors from Streptomyces. , 1989, The Journal of antibiotics.

[16]  G. Weber,et al.  Enzymic programs of rat bone marrow and the impact of acivicin and tiazofurin. , 1988, Biochemical pharmacology.

[17]  T. Brown,et al.  Observation of inositol pentakis- and hexakis-phosphates in mammalian tissues by 31P NMR. , 1987, Biochemical and biophysical research communications.

[18]  S. Nahorski,et al.  Rapid formation of inositol 1,3,4,5-tetrakisphosphate following muscarinic receptor stimulation of rat cerebral cortical slices. , 1985, The Biochemical journal.

[19]  J. Liepnieks,et al.  Modulation of IMP dehydrogenase activity and guanylate metabolism by tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide). , 1984, The Journal of biological chemistry.

[20]  G. Weber.  Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture. , 1983, Cancer research.

[21]  Lewis Stevens,et al.  Fundamentals of Enzymology , 1982 .

[22]  G. Weber.  Enzymology of cancer cells (second of two parts). , 1977, The New England journal of medicine.

[23]  G. Weber.  Enzymology of cancer cells (first of two parts). , 1977, The New England journal of medicine.

[24]  H. Morris,et al.  Metabolism of hepatomas of different growth rates in situ and during ischemia. , 1971, Cancer research.

[25]  E. Bresnick,et al.  Rates of turnover of deoxythymidine kinase and of its template RNA in regenerating and control liver. , 1967, Cancer research.